REFERENCES
- Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. NEJM 1999; 341:4556–4562.
- Center for Disease Control and Prevention, 2002. Accessed on July 20, 2006 http://www.cdc.gov/idu/hepatitis/viral_hep_drug_use.pdf.
- Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, Monterroso ER, Garfein RS. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiology 2002; 155:645–653.
- Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Pub Health 1996; 86:655–661.
- Evans M, Stotts AL, Graham S, Schmitz J, Grabowski J. Hepatitis C knowledge assessment and counseling within the context of substance abuse treatment. Addict Disord Treat 2004; 3:18–26.
- Janz NK, Becker MN. The health belief model and preventive health behavior. Health Edu Qtrly 1984; 11:1–47.
- Gibson D, Choi K, Catania J, Sorensen J, Kegeles S. Psychosocial predictors of needle sharing among intravenous drug users. Int J Addict 1993; 28:973–981.
- Ross MW, Wodak A, Stowe A, Gold J. Explanations for sharing injection equipment in injecting drug users and barriers to safer drug use. Addiction 1994; 89:473–479.
- Navaline HA, Snider EC, Petro CJ, Tobin D, Metzger D, Alterman AI, Woody GE. Preparations for AIDS vaccine trials. An automated version of the Risk Assessment Battery (RAB): Enhancing the assessment of risk behaviors. AIDS Res Hum Retroviruses 1994; 10(Suppl 2):S281–283.
- Long JS. Regression Models for Categorical and Limited Dependent Variables. Thousand Oaks, CA: Sage, 1993.
- Craine N, Walker M, Carnwath T, Klee H. Hepatitis c testing and injecting risk behaviour: The results of a UK based pilot study. Int J Drug Policy 2004; 15:115–122.
- Wright NMJ, Tompkins CNE, Jones L. Exploring risk perception and behaviour of homeless injecting drug users diagnosed with hepatitis C. Health Soc Care Comm 2005; 13:75–83.
- Davis M, Rhodes T, Martin A. Preventing hepatitis c: ‘Common sense,’ ‘the bug’ and other perspectives from the risk narratives of people who inject drugs. Soc Sci Med 2004; 59:1807–1818.
- Lovell AM. Risking risk: The influence of types of capital and social networks on the injection practices of drug users. Soc Sci Med 2002; 55:803–821.
- Hagan H, Thiede H, Des Jarlais D. Hepatitis C virus infection among injection drug users – Survival analysis of time to seroconversion. Epidemiology 2004; 15:543–549.
- Rhodes R, Davis M, Judd A. Hepatitis C and its risk management among drug injectors in London: Renewing harm reduction in the context of uncertainty. Addiction 2004; 99:621–633.